# CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)

Study · id `cardio:ct-nct01905475` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01905475](<https://clinicaltrials.gov/study/NCT01905475>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01905475

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT01905475. Randomized; quadruple masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2015-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT01905475, source copy `cardio:ctgov-nct01905475-2016-06-10`, retrieved 2026-10-26)
- Start date: 2013-07 (registry gives no type) (ClinicalTrials.gov record NCT01905475, source copy `cardio:ctgov-nct01905475-2016-06-10`, retrieved 2026-10-26)
- Primary completion: 2015-10 (actual) (ClinicalTrials.gov record NCT01905475, source copy `cardio:ctgov-nct01905475-2016-06-10`, retrieved 2026-10-26)
- Completion: 2016-06 (actual) (ClinicalTrials.gov record NCT01905475, source copy `cardio:ctgov-nct01905475-2016-06-10`, retrieved 2026-10-26)
- Countries: Austria; Germany; Hungary; Poland; United Kingdom (ClinicalTrials.gov record NCT01905475, source copy `cardio:ctgov-nct01905475-2016-06-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01905475-2016-06-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)
- Acronym: CATCH-AMI
- Condition: Large Reperfused ST-Elevation Myocardial Infarction
- Intervention (Drug): POL6326
- Intervention (Drug): Placebo
- Lead sponsor: Polyphor Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)

## Provenance

Content hash: 9a41d1b67be2adf7ee2360b666b020fcced54c459a7aec4f5f6278ca80fe9543
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
